全文获取类型
收费全文 | 26258篇 |
免费 | 1358篇 |
国内免费 | 252篇 |
专业分类
耳鼻咽喉 | 213篇 |
儿科学 | 530篇 |
妇产科学 | 626篇 |
基础医学 | 2764篇 |
口腔科学 | 527篇 |
临床医学 | 2288篇 |
内科学 | 7661篇 |
皮肤病学 | 570篇 |
神经病学 | 2310篇 |
特种医学 | 912篇 |
外科学 | 4339篇 |
综合类 | 62篇 |
一般理论 | 5篇 |
预防医学 | 915篇 |
眼科学 | 350篇 |
药学 | 1385篇 |
中国医学 | 44篇 |
肿瘤学 | 2367篇 |
出版年
2024年 | 18篇 |
2023年 | 213篇 |
2022年 | 163篇 |
2021年 | 776篇 |
2020年 | 490篇 |
2019年 | 651篇 |
2018年 | 769篇 |
2017年 | 590篇 |
2016年 | 735篇 |
2015年 | 791篇 |
2014年 | 1006篇 |
2013年 | 1391篇 |
2012年 | 2138篇 |
2011年 | 2103篇 |
2010年 | 1232篇 |
2009年 | 1099篇 |
2008年 | 1928篇 |
2007年 | 1821篇 |
2006年 | 1664篇 |
2005年 | 1676篇 |
2004年 | 1528篇 |
2003年 | 1357篇 |
2002年 | 1249篇 |
2001年 | 167篇 |
2000年 | 116篇 |
1999年 | 171篇 |
1998年 | 222篇 |
1997年 | 202篇 |
1996年 | 157篇 |
1995年 | 184篇 |
1994年 | 152篇 |
1993年 | 136篇 |
1992年 | 88篇 |
1991年 | 76篇 |
1990年 | 89篇 |
1989年 | 53篇 |
1988年 | 47篇 |
1987年 | 39篇 |
1986年 | 53篇 |
1985年 | 51篇 |
1984年 | 58篇 |
1983年 | 41篇 |
1982年 | 51篇 |
1981年 | 32篇 |
1980年 | 43篇 |
1979年 | 26篇 |
1978年 | 16篇 |
1977年 | 18篇 |
1975年 | 24篇 |
1974年 | 20篇 |
排序方式: 共有10000条查询结果,搜索用时 211 毫秒
11.
Robert J. Motzer MD Bernard Escudier MD Saby George MD Hans J. Hammers MD PhD Sandhya Srinivas MD Scott S. Tykodi MD PhD Jeffrey A. Sosman MD Elizabeth R. Plimack MD Giuseppe Procopio MD David F. McDermott MD Daniel Castellano MD Toni K. Choueiri MD Frede Donskov MD PhD Howard Gurney MD Stéphane Oudard MD Martin Richardet MD PhD Katriina Peltola MD PhD Ajjai S. Alva MD Michael Carducci MD John Wagstaff MD Christine Chevreau MD Satoshi Fukasawa MD Yoshihiko Tomita MD PhD Thomas C. Gauler MD Christian K. Kollmannsberger MD Fabio A. Schutz PhD James Larkin MD PhD David Cella PhD M. Brent McHenry PhD Shruti Shally Saggi BEng Nizar M. Tannir MD 《Cancer》2020,126(18):4156-4167
12.
13.
14.
15.
16.
Raffaella Marcheselli Alessia Bari Tamar Tadmor Luigi Marcheselli Maria Christina Cox Robel Papotti Angela Ferrari Luca Baldini Paolo Gobbi Ilana Levy Giuseppe Pugliese Massimo Federico Aaron Polliack Samantha Pozzi Stefano Sacchi 《Hematological oncology》2020,38(4):439-445
The main purpose of this study was to assess whether it is possible to improve the prognostic impact of international prognostic index (IPI) score by combining it with peripheral blood counts. Thus, we evaluated the prognostic power of lymphocyte, neutrophil, and monocyte counts in 520 patients with diffuse large B cell lymphoma treated with R-CHOP, confirming that these parameters have a strong impact on overall survival (OS). Using revised IPI (R-IPI), 44% of patients were categorized as poor-risk and showed an OS at 5 years of 46%. As OS at 5 years of the 520 patients is 67%, it is clearly evident that R-IPI tends to overestimate the proportion of patients with poor prognosis. Accordingly, in an attempt to improve the discriminating power of R-IPI, we evaluated and compared three different scores by combining the neutrophil lymphocyte ratio (NLR) and absolute monocyte count (AMC) with the following values: (a) IPI score 3-5, (b) age > 60 years and performance status, (c) age ≥ 65 years and LDH > ULN. The three indexes studied, had a similar 5 years OS for the high-risk group (46%-52%), but the proportion of patients classified as poor-risk were 37%, 20%, and 32%, respectively, which are lower than 44% identified with R-IPI. Thus, while R-IPI overestimates the number of high-risk patients, after applying our models, it is possible to recognize patients who are truly at high-risk. Of the three scores, the most accurate appears to be that based on NLR, AMC, LDH > ULN and age ≥ 65 years, which identifies 32% of high-risk patients, correlating well with what is seen in clinical practice. 相似文献
17.
18.
Oliver Sartor MD Daniel Heinrich MD Neil Mariados MD Maria José Méndez Vidal MD Daniel Keizman MD Camilla Thellenberg Karlsson MD Avivit Peer MD Giuseppe Procopio MD Stephen J. Frank MD Kalevi Pulkkanen MD Eli Rosenbaum MD Stefano Severi MD José Trigo MD Lucia Trandafir MD Volker Wagner MD Rui Li MS Luke T. Nordquist MD 《The Prostate》2019,79(14):1683-1691
19.
Carlo Bastianelli V. Bruni Ivo Brosens Giuseppe Benagiano 《Expert review of clinical pharmacology》2020,13(2):163-182
ABSTRACTIntroduction: Steroid hormones are responsible for specific changes in the endometrium during the menstrual cycle, when they are sequentially secreted and, because of this, in the early days sequential combined oral contraceptive regimens were utilized. The same basic concept has been utilized with multi-phasic regimens, in order to produce endometrial pictures mimicking the normal cycle.Areas covered: The Endometrial effects of progestins and estrogens; combined monophasic high- (50 μg), medium- (30 μg), low- (20 μg), ultralow- (15 μg) estrogen content; sequential regimens; multiphasic combinations; treatment schedules.Cervical effects of combined high-dose and sequential combinations, including evidence for an increase in malignant lesions.Expert opinion: Overall, combined oral contraceptives (COCs) inhibit normal proliferative changes and the endometrium becomes thin, narrow, with widely spaced glands and pre-decidual changes in the stroma. During the first few cycles the progestin induces a coexistence of proliferative and secretory features; with time, the picture changes because the progestin induces a down-regulation of estrogen receptors, resulting in tortuous glands similar to those in the secretory phase, but characterized by a quiescent, atrophic glandular epithelium.In the cervical epithelium, under the influence of high-dose COCs, endocervical glands became hypersecretory and in some instances, distinctive type of atypical polypoid endocervical hyperplasia is found. 相似文献
20.
Federico Giuseppe Usuelli Cristian Indino Camilla Maccario Luigi Manzi Federico Maria Liuni Ettore Vulcano 《Foot and Ankle Surgery》2019,25(1):19-23